Titan Medical Inc.  

(Public, CVE:TMD)   Watch this stock  
Find more results for Bruce A. Wolffing
Sep 29 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.38 - 2.76
Open     -
Vol / Avg. 0.00/48,846.00
Mkt cap 249.34M
P/E     -
Div/yield     -
EPS -0.20
Shares 101.80M
Beta 0.05
Inst. own     -
May 12, 2015
Q1 2015 Titan Medical Inc Earnings Release

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -114.12% -69.70%
Return on average equity -145.85% -85.01%
Employees 12 -
CDP Score - -


Suite 1000, 170 University Avenue
+1-416-5487522 (Phone)

Website links


Titan Medical Inc. (Titan) is a Canada-based development-stage company. The Company is focused on the development and commercialization of robotic surgical technologies. The Company’s Single Port Orifice Robotic Technology, SPORT Surgical System, currently under development, consist of a surgeon controlled robotic platform that includes a three dimensional (3D) vision system and interactive instruments for Performing Management Information System (MIS) procedures. The SPORT Surgical System is being designed to expand robotic surgery into both simple and complex areas of surgical specialties and procedures that are currently under serviced. It is also being designed to allow surgeons to perform procedures within small to medium size surgical spaces, including general abdominal, gynecologic and urologic procedures.

Officers and directors

John T. Hargrove Chairman of the Board, Chief Executive Officer
Reiza Rayman M.D. President, Director
Age: 51
Stephen D. Randall Chief Financial Officer, Secretary
Dennis L. Fowler Executive Vice President - Clinical and Regulatory Affairs
John E. Barker Independent Director
Age: 67
Martin C. Bernholtz CPA Independent Director
Bruce Gilles Wolff M.D. Independent Director